Hints and tips:
...GSK has been under investigation since 2011 in a so-called pay-for-delay case, where it is alleged to have paid several smaller pharmaceutical companies — including Alpharma, Generics UK and Ivax — to delay...
...Mr Frost, who is based in Florida, joined Teva’s board when it acquired his generics business Ivax in 2006....
...In addition, Phillip Frost, the chairman, previously ran Ivax, which Teva acquired in 2006....
...In Europe, the competition directorate gave the issue a new prominence in a pharmaceutical “sectoral inquiry” that warned such practices could violate EU law....
...In a brief statement, the OFT alleged that GSK had made agreements with three smaller drugmakers – Alpharma, Generics UK and Ivax – to delay their production of the paroxetine which had, the company believed...
...Either way, it now accounts for 11 per cent of global pharmaceutical sales and is growing at more than 10 per cent annually, twice the rate of the patented sector....
...•Isaac Kaye: Mr Kaye is the former chairman of Harris Pharmaceuticals, a generic medicine business, which he sold to a US group called Ivax in 1990. He gave £10,000....
...Israel’s Teva is another group that is expanding aggressively, either through acquisition (the $7.4bn purchase of Ivax in the US, for example) or by challenging patents in the courts....
...It marks the latest chapter in the consolidation of the generic drugs sector, which has witnessed Teva’s $7.4bn takeover of Ivax, and Barr Pharmaceuticals’ purchase of Croatia’s Pliva for $2.5bn....
...But Mr Condella, who was credited with increasing profit at the European business of Ivax, before it was bought by Teva last year, says one of the things that attracted him was the challenge....
...Moreover, many generics companies, including Teva and Ivax, are working to develop their own high-margin branded pharmaceuticals....
...Teva, however, did not take long to respond to the Novartis challenge, buying US rival Ivax for $7.4bn to regain its crown....
...Last week the Israeli drugs group regained its position as the number one seller of generic drugs after agreeing to buy Ivax of the US for $7.4bn....
...Teva Pharmaceutical is the largest manufacturer of generic drugs worldwide. Along with sound financials, it is close to a deal with Ivax that would increase its exposure to the US market....
...In other merger and acquisitions news, Teva Pharmaceutical, the Israeli generic drugs manufacturer, said it was in advanced talks to buy Ivax, a maker of asthma treatments, in a deal worth about $7.4bn....
...Warsaw now has four non-Polish listings, Bank Austria, US-based Ivax, a pharmaceutical company, German computer company BMP AG, and Borsodchem, a Hungarian chemical company....
...Singer, Chairman, Oscient Pharmaceuticals, Founding CEO, Affymetrix Marva Smalls, Executive Vice President, Public Affairs and Chief of Staff, Nickelodeon Networks Jeffrey H....
International Edition